D. Ranjan, A. Sharma, and R. B. Bodla, “Saxagliptin and Dapagliflozin for type 2 Diabetes mellitus: A Review”, Int J Drug Reg Affairs, vol. 6, no. 3, pp. 24-30, Sep. 2018.